Anapharm Bioanalytics is proud to announce that it has successfully undergone another US FDA inspection at its Barcelona based bioanalytical lab. The inspection, that took place in June 2019, had a focus on a total of 8 studies. This was the second unannounced FDA inspection at our facilities without any observations; no 483 form issued.

Con gran éxito culminó nuestro II Workshop de Bioequivalencia 2019, al que asistieron importantes laboratorios farmacéuticos, en dónde pudieron compartir sus experiencias y resolver inquietudes sobre los Estudios de Biodisponibilidad y Bioequivalencia y su aprobación por parte del INVIMA.